Drug Combo Fails to Improve Mesothelioma Survival
Adding the VEGF-inhibitor bevacizumab to a popular chemotherapy combination for mesothelioma does not appear to prolong survival after all. Scientists at 11…
Orphan Drug Shows Survival Advantage in Mesothelioma
Long-term follow-up on a second-line drug for mesothelioma confirms its potential for prolonging survival. NGR-hTNF is a vascular targeting agent that…
New Molecule May Aid Mesothelioma Diagnosis
Scientists at one of the nation’s top cancer centers say they have come up with a new imaging tool that…
States Wrestle with Legal Side of Mesothelioma
Recent changes in the way some states handle mesothelioma lawsuits may eventually have an impact nationwide. In Pennsylvania, the state Supreme Court…
Landlord’s Action Puts Tenants at Mesothelioma Risk
Property owners who want to remove asbestos are being urged to heed a lesson learned the hard way by a…
Unions Call for Asbestos-Free Australia
The head of an Australian Consortium of Trade Unions (ACTU) is calling on the government to protect its citizens against…
Mesothelioma Risk Depends on Asbestos Fiber Size
Scientists who study the connection between asbestos fibers and mesothelioma say they now understand what size particles pose the most danger.…
Alaska Lawmakers Allow Asbestos in Gravel
Alaska lawmakers have decided not to let the threat of mesothelioma stand in the way of progress. In April, the state legislature…
Finding the Mesothelioma Asbestos Connection
Even though the cause of mesothelioma – exposure to asbestos – is well-known, it is not always easy for a mesothelioma patient…
Effectiveness of Mesothelioma Drug Improved by Other Compounds
Two new studies suggest that a popular mesothelioma drug becomes more effective when combined with other compounds. Pemetrexed (Alimta) is considered…